Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Protofibril-binding antibodies and their use in thereapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other alpha-synucleinopathies

Protofibril-binding antibodies and their use in thereapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other alpha-synucleinopathies

US Patent 8859501 · Granted Oct 14, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Brain delivery protein2022
α-synuclein protofibril-binding antibodies2022
Method for treatment of traumatic brain injury targeting aggregated peptides2022
Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synu2016
Protofibril-binding antibodies and their use in therapeutic and diagnostic metho2015
Protofibril-binding antibodies and their use in therapeutic and diagnostic metho2015
Protofibril-binding antibodies and their use in therapeutic and diagnostic metho2015
Protofibril-binding antibodies and their use in therapeutic and diagnostic metho2015
Protofibril-binding antibodies and their use in therapeutic and diagnostic metho2015
Protofibril-binding antibodies and their use in therapeutic and diagnostic metho2015
Protofibril selective antibodies and the use thereof2015
Antibodies specific for soluble amyloid beta peptide protofibrils and uses there2015